Marinvent and AdvAero join Ohio/Indiana UASC&TC User Advisory Panel

Marinvent announces today that it has signed an agreement to join the Ohio/Indiana UAS Center & Test Complex (UASC&TC) User Advisory Panel along with its US-Joint Venture partner, Advanced Aerospace Solutions (AdvAero).

The User Advisory Panel has been formed in support of the Ohio/Indiana team's bid to be selected under the recently announced Federal Aviation Administration (FAA) UAS Test Site Screening Information Request (SIR).

"Marinvent is proud to be a part of the Ohio/Indiana bid team together with our US-based Joint Venture (JV) partners Advanced Aerospace Solutions (AdvAero)," said Phil Cole, VP Business Development at Marinvent Corporation. "The UASC&TC User Advisory Panel is incredibly significant because it brings together a diverse set of stakeholders representing system developers/integrators and subsystem developers with operational interests in research, development, test and evaluation and training."

The Unmanned Aircraft Systems (UAS) industry is projected to become a $94 billion industry by 2020. One of the key barriers to the emergence of the UAS industry is the ability to integrate UAS into the National Airspace System (NAS) to support military and commercial operations, training, and testing. The States of Ohio and Indiana provide a confluence of military and civil resources that enables the creation of a leadership role in future UAS development and production. The Ohio/Indiana UASC&TC will focus critical resources on UAS research, development, test, manufacturing and training to the benefit of Federal, State and commercial users.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.